Publications by authors named "Mutlu Pelin"

Claim this Profile
U
Usnic Acid induces dual-pathway apoptosis in SKOV-3 ovarian cancer cells via PARP1 inhibition and MAPK pathway activation.
Mehmet Kürşat Derici, Mine Ensoy, Pelin Mutlu, Demet Cansaran-Duman

Hum Exp Toxicol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential synergistic effects of palbociclib and doxorubicin on doxorubicin-resistant cancer cells with diverse tumor origins.
Gizem Damla Yalcin, Pelin Mutlu, Hasan Huseyin Kazan, Ufuk Gunduz

J Chemother· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evernic Acid: A Low-Toxic and Selective Alternative to Chemotherapeutic Agents in the Treatment of Ovarian Cancer.
Mine Ensoy, Damla Nur Parıltı, Ayşe Hale Alkan, Kübra Nur Kaplan İlhan, Pelin Mutlu

Arch Pharm (Weinheim)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, Anticancer Activity, and Modeling of Alkylsulfonyl Benzimidazole Derivatives: Unveiling Potent Bcl-2 Inhibitors for Breast Cancer.
Yemna Abbade, Mehmet Murat Kisla, Mohammed Al-Kassim Hassan, Ismail Celik, Tugba Somay Dogan, Pelin Mutlu

ACS Omega· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug metabolism and inflammation related distinct miRNA signature of colchicine resistant familial Mediterranean fever patients.
Bilgesu Şafak Tümerdem, Tayfun Hilmi Akbaba, Ezgi Deniz Batu, Yeliz Z Akkaya-Ulum, Pelin Mutlu

Int Immunopharmacol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the Therapeutic Effects of Palbociclib Conjugated Magnetic Nanoparticles on Different Types of Breast Cancer Cell Lines.
Maryam Parsian, Pelin Mutlu, Negar Taghavi Pourianazar, Serap Yalcin Azarkan, Ufuk Gunduz

Cell Mol Bioeng· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vancomycin Containing PDLLA and PLGA/β-TCP Inhibit Biofilm Formation but Do Not Stimulate Osteogenic Transformation of Human Mesenchymal Stem Cells.
Berna Kankilic, Erdal Bayramli, Petek Korkusuz, Hakan Eroglu, Burcin Sener, Pelin Mutlu

Front Surg· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a microfluidic platform to maintain viability of micro-dissected tumor slices in culture.
Maryam Parsian, Pelin Mutlu, Ender Yildirim, Can Ildiz, Can Ozen

Biomicrofluidics· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Gemcitabine Loaded Polyhydroxybutyrate Coated Magnetic Nanoparticles for Targeted Drug Delivery.
Maryam Parsian, Pelin Mutlu, Serap Yalcin, Ufuk Gunduz

Anticancer Agents Med Chem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
Esra Metin, Pelin Mutlu, Ufuk Gündüz

Anticancer Agents Med Chem· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of the relationship between doxorubicin resistance and Wnt signaling pathway in HeLa and K562 cell lines.
Pelin Mutlu, Serap Yalçin Azarkan, Negar Taghavi Pourianazar, Meral Yücel, Ufuk Gündüz

EXCLI J· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery.
Maryam Parsian, Pelin Mutlu, Serap Yalcin, Aysen Tezcaner, Ufuk Gunduz

Int J Pharm· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loading of Gemcitabine on chitosan magnetic nanoparticles increases the anti-cancer efficacy of the drug.
Maryam Parsian, Gozde Unsoy, Pelin Mutlu, Serap Yalcin, Aysen Tezcaner

Eur J Pharmacol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.
Serap Yalçın, Pelin Mutlu, Türker Çetin, Meral Sarper, Gökhan Özgür

Turk J Haematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between XRCC3 Thr241Met polymorphism and laryngeal cancer susceptibility in Turkish population.
Pelin Mutlu, Murad Mutlu, Serap Yalçın, Atılay Yaylacı, Gözde Ünsoy

Eur Arch Otorhinolaryngol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on molecular biology and drug resistance mechanisms of multiple myeloma.
Pelin Mutlu, Yağmur Kiraz, Ufuk Gündüz, Yusuf Baran

Crit Rev Oncol Hematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of XRCC1 Arg399Gln and XRCC3 Thr241Met Polymorphisms in a Turkish Population and Their Association with the Risk of Chronic Lymphocytic Leukemia.
Pelin Mutlu, Mualla Pınar Elçi, Murat Yıldırım, Oral Nevruz, Ahmet Türker Çetin

Indian J Hematol Blood Transfus· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyhydroxybutyrate-coated magnetic nanoparticles for doxorubicin delivery: cytotoxic effect against doxorubicin-resistant breast cancer cell line.
Serap Yalcin, Gozde Unsoy, Pelin Mutlu, Rouhollah Khodadust, Ufuk Gunduz

Am J Ther· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of XRCC1 gene polymorphisms in Turkish head and neck squamous cell carcinoma patients: a comparative analysis with different populations.
Pelin Mutlu, Murad Mutlu, Serap Yalcin, Gozde Unsoy, Atilay Yaylaci

J BUON· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of -174G/C interleukin/6 gene polymorphism with the risk of chronic lymphocytic, chronic myelogenous and acute myelogenous leukemias in Turkish patients.
Pelin Mutlu, Serap Yalcin, Pinar Elci, Murat Yildirim, A Turker Cetin

J BUON· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Gozde Unsoy, Rouhollah Khodadust, Serap Yalcin, Pelin Mutlu, Ufuk Gunduz

Eur J Pharm Sci· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different types of cell cycle- and apoptosis-related gene expressions alter in corticosteroid-, vincristine-, and melphalan-resistant u-266 multiple myeloma cell lines.
Pelin Mutlu, Ali Uğur Ural, Ufuk Gündüz

Turk J Haematol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancer.
Ufuk Gunduz, Tugba Keskin, Gulistan Tansık, Pelin Mutlu, Serap Yalcin

Biomed Pharmacother· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy.
Gozde Unsoy, Serap Yalcin, Rouhollah Khodadust, Pelin Mutlu, Onder Onguru

Biomed Pharmacother· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxorubicin loading, release, and stability of polyamidoamine dendrimer-coated magnetic nanoparticles.
Khodadust Rouhollah, Mutlu Pelin, Yalcin Serap, Unsoy Gozde, Gunduz Ufuk

J Pharm Sci· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis